RETA Reata Pharmaceuticals, Inc. Net earnings per share for the last 12 months

RETA (Reata Pharmaceuticals Inc) - company brandmark

Reata Pharmaceuticals (RETA) is implementing eco-friendly chemical synthesis and zero-waste laboratory cycles. The company's annual revenue per unit visualizes this progress, where the -2.99 level captures the latest values. A monopoly status in Friedreich's ataxia therapy precludes dumping, while the inelastic demand for Skyclarys guarantees a steady cash flow, ensuring the high commercial resilience of the patent portfolio.

RETA Reata Pharmaceuticals Earnings per share for the trailing year (07/04/2022 - 10/07/2023)

Reata Pharma - analytical breakdowns and key metrics (RETA)

- stock price and consensus target price:
Basic company analysis:reatapharma.com (RETA)
Mass-produced product of Reata

Net income per share over 12 months measures actual equity income, excluding the impact of volatility in the number of securities. The integration of Reata Pharmaceuticals (RETA) teams into Biogen structures stabilizes operating expenses, directly affecting the calculation base of this metric. This chart of net income per share over 12 months allows for the elimination of accounting distortions. This price action confirms the effectiveness of retaining key competencies, which guarantees capital stability over the long term.

Analysis of competing companies

Jazz Pharmaceuticals Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytokinetics Inc|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Zevra Corp - Earnings per share for the last twelve months|CTNM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Larimar Therapeutics|CAPR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Entrada TRDA|Net earnings per share for the last 12 months PTHS|Net earnings per one share for the last twelve months medicinova.com MNOV|Net earnings per share (EPS TTM) SER|Earnings per share for the last twelve months BTAI (BioXcel Therapeutics)|Earnings per share for the last twelve months ProMIS Neurosciences, Inc. PMN|APUS (Apimeds) - Earnings per one share for the last 12 months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year